Skip to main
UHS

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 10 analyst ratings
Buy
Strong Buy 30%
Buy 0%
Hold 70%
Sell 0%
Strong Sell 0%

Bulls say

Universal Health Services is a strong investment opportunity and its positive outlook is driven by several key factors: strong volume and pricing trends in the company's behavioral health centers leading to higher profitability, expectations of continued positive growth in volume and margins, and a discounted valuation compared to industry peers. There are some risks, such as potential impacts to Medicaid funding and possible regulatory scrutiny, but overall, the company's diverse portfolio of services and strong leadership make it a solid investment choice.

Bears say

Universal Health Services is facing several fundamental challenges, including a recent cyberattack that has led to financial losses, a decline in HIX volumes due to the expiration of enhanced ACA subsidies, and difficulties in achieving core EBITDA growth. The company's exposure to certain markets, particularly Nevada, Texas, and California, also presents potential risks. While the company's investment in energy efficiency and waste reduction initiatives is commendable, its reliance on a large workforce and potential issues around diversity and inclusion could also impact its operations. Overall, the company's execution risk and limited upside potential in a competitive healthcare industry lead to a negative outlook for its stock.

UHS has been analyzed by 10 analysts, with a consensus rating of Buy. 30% of analysts recommend a Strong Buy, 0% recommend Buy, 70% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Buy based on their latest research and market trends.

According to 10 analysts, UHS has a Buy consensus rating as of Aug 22, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $195.40, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $195.40, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.